Table 1.
Demographic, clinical features, laboratory data on admission
| Total (n = 51) | Positive cases (n = 25) | Negative cases (n = 26) | p value | |
|---|---|---|---|---|
| Age, years | 47.0 (40.5–55.0) | 47.0 (43.0–55.0) | 46.5 (35.0–53.0) | 0.491 |
| Sex | 0.645 | |||
| Female | 20 (39.2%) | 9 (36.0%) | 11 (42.3%) | |
| Male | 31 (60.8%) | 16 (64.0%) | 15 (57.7%) | |
| Underlying diseases | 10 (19.6%) | 7 (28.0%) | 3 (11.5%) | 0.260 |
| Exposure history | 43 (84.3%) | 22 (88.0%) | 21 (80.8%) | 0.745 |
| Fever (temperature ≥ 37.3 °C) | 37 (72.5%) | 19 (76.0%) | 18 (69.2%) | 0.588 |
| Cough | 29 (56.9%) | 11 (44.0%) | 18 (69.2%) | 0.069 |
| Fatigue | 7 (13.7%) | 2 (8.0%) | 5 (19.2%) | 0.575 |
| Disease severity status | 0.280 | |||
| Asymptomatic | 5 (9.8%) | 4 (16.0%) | 1 (3.8%) | |
| General | 40 (78.4%) | 19 (76.0%) | 21 (80.8%) | |
| Severe | 6 (11.8%) | 2 (8.0%) | 4 (15.4%) | |
| Lymphocyte count | 1038.88 ± 479.18 | 1017.35 ± 376.01 | 1027.90 ± 425.47 | 0.859 |
Data are given as n (%) or median (IQR) or